Workflow
TTD Banks on Kokai's Widespread Adoption: Path to Greater Monetization?
ZACKS· 2025-08-22 14:15
Launched by The Trade Desk, Inc. ((TTD) in 2023, Kokai is a next-generation platform that integrates advanced AI, enhanced measurement, expanded partner integrations and a streamlined user experience, enabling marketers at all levels to fully harness the advantages of programmatic advertising. Kokai empowers advertisers with unmatched capabilities to achieve greater precision and relevance across all activities, driven by Koa, the industry's most advanced AI technology. The Trade Desk has integrated AI acro ...
Ahead of Donaldson (DCI) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Wall Street analysts expect Donaldson (DCI) to post quarterly earnings of $1.02 per share in its upcoming report, which indicates a year-over-year increase of 8.5%. Revenues are expected to be $953.79 million, up 2% from the year-ago quarter. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. The collective assessment of analysts points ...
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?
ZACKS· 2025-08-22 14:15
Have you been paying attention to shares of ANI Pharmaceuticals (ANIP) ? Shares have been on the move with the stock up 36.5% over the past month. The stock hit a new 52-week high of $91.54 in the previous session. ANI has gained 64.9% since the start of the year compared to the -2.4% move for the Zacks Medical sector and the 4.1% return for the Zacks Medical - Biomedical and Genetics industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surprises, as it hasn't ...
Unlocking Q4 Potential of Nutanix (NTNX): Exploring Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Wall Street analysts forecast that Nutanix (NTNX) will report quarterly earnings of $0.32 per share in its upcoming release, pointing to a year-over-year increase of 18.5%. It is anticipated that revenues will amount to $642.76 million, exhibiting an increase of 17.3% compared to the year-ago quarter. Based on the collective assessment of analysts, 'Disaggregation of Revenue- Subscription revenue' should arrive at $612.30 million. The estimate indicates a year-over-year change of +18.1%. Analysts predict th ...
Ahead of Guess (GES) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Wall Street analysts expect Guess (GES) to post quarterly earnings of $0.14 per share in its upcoming report, which indicates a year-over-year decline of 66.7%. Revenues are expected to be $757.14 million, up 3.4% from the year-ago quarter. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Prior to a company's earnings release, it is of ...
Ahead of Abercrombie (ANF) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Analysts on Wall Street project that Abercrombie & Fitch (ANF) will announce quarterly earnings of $2.27 per share in its forthcoming report, representing a decline of 9.2% year over year. Revenues are projected to reach $1.19 billion, increasing 4.8% from the same quarter last year. The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial proje ...
Unveiling Snowflake (SNOW) Q2 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
The upcoming report from Snowflake Inc. (SNOW) is expected to reveal quarterly earnings of $0.26 per share, indicating an increase of 44.4% compared to the year-ago period. Analysts forecast revenues of $1.09 billion, representing an increase of 24.9% year over year. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Ahead of a company's earning ...
Insights Into Kohl's (KSS) Q2: Wall Street Projections for Key Metrics
ZACKS· 2025-08-22 14:15
The upcoming report from Kohl's (KSS) is expected to reveal quarterly earnings of $0.33 per share, indicating a decline of 44.1% compared to the year-ago period. Analysts forecast revenues of $3.48 billion, representing a decline of 6.9% year over year. The consensus EPS estimate for the quarter has undergone an upward revision of 2.9% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe. B ...
Unveiling Agilent (A) Q3 Outlook: Wall Street Estimates for Key Metrics
ZACKS· 2025-08-22 14:15
Core Viewpoint - Agilent Technologies is expected to report quarterly earnings of $1.37 per share, a 3.8% increase year-over-year, with revenues projected at $1.66 billion, reflecting a 5.1% year-over-year increase [1]. Financial Projections - Analysts have not revised the consensus EPS estimate for the quarter in the last 30 days, indicating stability in forecasts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock price performance [3]. Revenue Estimates by Segment - The estimated 'Net Revenue- Life Sciences and Diagnostics Markets Segment' is $631.29 million, showing a year-over-year decrease of 19.3% [5]. - 'Net Revenue- Agilent Crosslab Group' is expected to reach $720.15 million, indicating a significant year-over-year increase of 75.2% [5]. - 'Revenue by End Markets- Chemical and advanced materials' is projected at $376.71 million, reflecting a 5.8% increase from the prior year [6]. - 'Revenue by End Markets- Environmental and Forensics' is estimated at $170.70 million, with a year-over-year change of 1.6% [6]. - 'Revenue by End Markets- Diagnostics and Clinical' is expected to be $249.80 million, indicating a 3.2% increase from the previous year [7]. - The consensus for 'Revenue by End Markets- Academia and Government' stands at $137.61 million, reflecting a year-over-year increase of 7.5% [7]. - 'Revenue by End Markets- Pharmaceutical' is projected at $581.31 million, indicating a year-over-year increase of 7.7% [7]. - 'Revenue by End Markets- Food' is expected to reach $150.33 million, reflecting a 4.4% increase from the prior year [8]. Stock Performance - Over the past month, Agilent shares have decreased by 2.7%, while the Zacks S&P 500 composite has increased by 1.1% [8]. - Agilent holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the upcoming period [8].
Stay Ahead of the Game With CrowdStrike (CRWD) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-08-22 14:15
Wall Street analysts forecast that CrowdStrike Holdings (CRWD) will report quarterly earnings of $0.83 per share in its upcoming release, pointing to a year-over-year decline of 20.2%. It is anticipated that revenues will amount to $1.15 billion, exhibiting an increase of 19.2% compared to the year-ago quarter. The average prediction of analysts places 'Revenue- Subscription' at $1.10 billion. The estimate points to a change of +19.5% from the year-ago quarter. The consensus estimate for 'Revenue- Professio ...